Related references
Note: Only part of the references are listed.Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization study
Venexia M. Walker et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2020)
Counter-regulatory renin-angiotensin system in cardiovascular disease
Maria Paz Ocaranza et al.
NATURE REVIEWS CARDIOLOGY (2020)
ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease
Charles E. Evans et al.
ACTA NEUROPATHOLOGICA (2020)
Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies
Jie Ding et al.
LANCET NEUROLOGY (2020)
Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis
Ruth Peters et al.
NEUROLOGY (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration
Chin Hong Tan et al.
BRAIN (2019)
Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time
Chris Moran et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats
Henning J. Drews et al.
NEUROTHERAPEUTICS (2019)
Synergism between fornix microstructure and beta amyloid accelerates memory decline in clinically normal older adults
Jennifer S. Rabin et al.
NEUROBIOLOGY OF AGING (2019)
Divergence in the activity of the N- and C- catalytic domains of ACE1-implications for the role of the renin-angiotensin system in Alzheimer's disease
Noura S. AL Mulhim et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
The Relationship Between the Use of Antihypertensive Drugs and the Incidence of Dementia in General Practices in Germany
Jens Bohlken et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model
Saffire H. Krance et al.
JOURNAL OF NEUROSCIENCE (2019)
Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
Niklas Mattsson et al.
JAMA NEUROLOGY (2019)
Vascular Risk and β-Amyloid Are Synergistically Associated with Cortical Tau
Jennifer S. Rabin et al.
ANNALS OF NEUROLOGY (2019)
Getting to the Heart of Alzheimer Disease
Joshua M. Tublin et al.
CIRCULATION RESEARCH (2019)
Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia
Fabricio Ferreira de Oliveira et al.
CURRENT ALZHEIMER RESEARCH (2018)
The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
Patrick Gavin Kehoe
JOURNAL OF ALZHEIMERS DISEASE (2018)
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
Brian Lawlor et al.
PLOS MEDICINE (2018)
The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity
Douglas Berthold et al.
PLOS ONE (2018)
Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study
Jodi D. Edwards et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Dementia prevention, intervention, and care
Gill Livingston et al.
LANCET (2017)
In vivo staging of regional amyloid deposition
Michel J. Grothe et al.
NEUROLOGY (2017)
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Chia-Chen Liu et al.
NEURON (2017)
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
Sebastian Palmqvist et al.
NATURE COMMUNICATIONS (2017)
Association between Antihypertensive Drug Use and the Incidence of Cognitive Decline and Dementia: A Meta-Analysis of Prospective Cohort Studies
Guangli Xu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function
Amanda M. DiBattista et al.
CURRENT ALZHEIMER RESEARCH (2016)
Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention
Daniel A. Nation et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-beta (A beta) Plaque Load and A beta-Synthesizing and A beta-Degrading Enzymes in Frontal Cortex
Emma L. Ashby et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Hypertension and Dementia: Epidemiological and Experimental Evidence Revealing a Detrimental Relationship
Marialuisa Perrotta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
Kah L. Goh et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios
Susan M. Landau et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
Masato Furuhashi et al.
AMERICAN JOURNAL OF HYPERTENSION (2015)
Angiotensin Converting Enzyme Inhibitors and Alzheimer Disease in the Presence of the Apolipoprotein E4 Allele
Wendy Wei Qiao Qiu et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Amyloid-beta Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods
Susan M. Landau et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Antihypertensive medication use and risk of cognitive impairment The Honolulu-Asia Aging Study
Rebecca P. Gelber et al.
NEUROLOGY (2013)
Antihypertensive drugs decrease risk of Alzheimer disease Ginkgo Evaluation of Memory Study
Sevil Yasar et al.
NEUROLOGY (2013)
Brain β-amyloid load approaches a plateau
Clifford R. Jack et al.
NEUROLOGY (2013)
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
Philip B. Verghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Neprilysin and Aβ clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease
Marcus O. W. Grimm et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series
Ihab Hajjar et al.
ARCHIVES OF NEUROLOGY (2012)
Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature
Daniela Carnevale et al.
HYPERTENSION (2012)
Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
Lusine Danielyan et al.
REJUVENATION RESEARCH (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Effects of Antihypertensive Therapy on Cognitive Decline in Alzheimer's Disease
Emmanuelle Duron et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
Albert Fournier et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Angiotensin Receptor Blocker Prevented β-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling
Shuko Takeda et al.
HYPERTENSION (2009)
Review: Blood pressure and dementia — a comprehensive review
Sean P. Kennelly et al.
Therapeutic Advances in Neurological Disorders (2009)
Telmisartan prevented cognitive decline partly due to PPAR-γ activation
Masaki Mogi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Angiotensin-converting enzyme converts amyloid β-protein 1-42 (Aβ1-42) to Aβ1-40, and its inhibition enhances brain aβ deposition
Kun Zou et al.
JOURNAL OF NEUROSCIENCE (2007)
Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor
ML Hemming et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Does the angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? A systematic review
M Scharplatz et al.
CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE (2005)
The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide
R Oba et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI
MD Greicius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Angiotensin II-receptor blockers: Clinical relevance and therapeutic role
JE Rodgers et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2001)
Share Paper
